Clinical trial
Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression
NCT00034229 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00034229 |
|---|---|
| Title | Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression |
| Official title | A Double-Blind Randomized Placebo-Controlled Trial of Felbamate in Treatment Resistant Bipolar Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Felbamate |
| Enrollment | 52 |
| Start date | Apr 1, 2002 |
| Completion | Mar 1, 2006 |
| First posted | Apr 24, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: